Mesalazine Price in Australia (2026)
Cheapest 1000 mg tablet: Salofalk, A$57.26 for 60 tablets. Official PBS price list, Oct 2026.
≈ $0.67 per tabletWhat a patient pays for mesalazine in Australia
Most a general patient pays per PBS prescription (A$7.70 with a concession card). If the medicine costs the pharmacy less than this, you pay the lower dispensed price.
8 different brand names across 10 strengths are on the official list.
has the lowest listed price per tablet for the same strength: $0.62 vs $0.67 here (different price types; see below).
How much will Mesalazine 1000 mg tablet cost you?
All 24 mesalazine products in Australia
| Product | Strength and form | Pack | Price | Per unit |
|---|---|---|---|---|
| Salofalk original | Tablet 1 g (enteric coated) | 60 tablets | A$57.26 | A$0.95 |
| Salofalk original | Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g | 1 | A$53.00 | — |
| Pentasa original | Tablet 500 mg (prolonged release) | 100 | A$50.78 | A$0.51 |
| Pentasa original | Tablet 1 g (prolonged release) | 60 | A$56.97 | A$0.95 |
| Mesalazine 1.2 TAKEDA | Tablet 1.2 g (prolonged release) | 60 | A$73.13 | A$1.22 |
| Mezavant original | Tablet 1.2 g (prolonged release) | 60 | A$73.13 | A$1.22 |
| MEZTAS | Tablet 1.2 g (prolonged release) | 60 | A$73.13 | A$1.22 |
| MESALZ | Tablet 1.2 g (prolonged release) | 60 | A$146 | A$2.44 |
| Salofalk original | Sachet containing granules, 500 mg per sachet | 100 | A$50.78 | — |
| Pentasa original | Sachet containing prolonged release granules, 1 g per sachet | 100 | A$86.97 | — |
| Salofalk original | Sachet containing granules, 1 g per sachet | 100 | A$94.95 | — |
| Salofalk original | Sachet containing granules, 1.5 g per sachet | 60 | A$82.03 | — |
| Pentasa original | Sachet containing prolonged release granules, 2 g per sachet | 60 | A$107 | — |
| Salofalk original | Sachet containing granules, 3 g per sachet | 30 | A$82.03 | — |
| Pentasa original | Sachet containing prolonged release granules, 4 g per sachet | 30 | A$107 | — |
| Pentasa original | Enemas 1 g in 100 mL, 7 | 7 | A$45.80 | — |
| Pentasa original | Suppository 1 g | 28 | A$64.80 | — |
| Salofalk original | Suppository (moulded) 1 g | 30 | A$80.33 | — |
| Salofalk original | Enemas 2 g in 60 mL, 7 | 7 | A$45.80 | — |
| Salofalk original | Enemas 4 g in 60 mL, 7 | 7 | A$71.64 | — |
| Mesasal original | Tablet 250 mg (enteric coated) | 100 tablets | A$29.43 | A$0.29 |
| Salofalk original | Tablet 500 mg (enteric coated) | 100 tablets | A$50.78 | A$0.51 |
| Asacol original | Tablet 800 mg (enteric coated) | 90 tablets | A$61.06 | A$0.68 |
| Asacol original | Tablet 1.6 g (enteric coated) | 60 tablets | A$64.32 | A$1.07 |
Mesalazine 1000 mg tablet: Australia vs 2 other countries
| Country | Price type | Per tablet (local) | Per unit (USD) |
|---|---|---|---|
| United Arab Emirates | Abu Dhabi DoH public price | AED 2.29 | $0.62 |
| United Kingdom | NHS Drug Tariff price | £0.65 | $0.87 |
Countries publish different kinds of price (manufacturer, reimbursement or retail), so differences are partly due to what is measured. Converted at official US dollar pegs (AED, SAR) and ECB reference rates of 23 October 2026.
How PBS prices work in Australia
Prices on this page are the approved ex-manufacturer price on the Pharmaceutical Benefits Scheme (PBS): what the Australian Government has agreed to pay the supplier for the pack. Pharmacy mark-up and dispensing fees are added on top. Patients with a PBS prescription do not pay this price; they pay a government-capped co-payment (lower for concession card holders), and the PBS covers the rest.
Every strength and form of mesalazine in Australia
| Strength and form | Products | Cheapest pack | Cheapest per unit |
|---|---|---|---|
| 1200 mg modified-release tablet | 4 | A$73.13 | A$1.22 |
| 1000 mg suppository | 3 | A$45.80 | — |
| 1000 mg powder | 2 | A$86.97 | — |
| 1000 mg tablet | 1 | A$57.26 | A$0.95 |
| 1000 mg inhaler | 1 | A$53.00 | — |
| 500 mg modified-release tablet | 1 | A$50.78 | A$0.51 |
| 1000 mg modified-release tablet | 1 | A$56.97 | A$0.95 |
| 500 mg powder | 1 | A$50.78 | — |
| 1500 mg powder | 1 | A$82.03 | — |
| 2000 mg powder | 1 | A$107 | — |
| 3000 mg powder | 1 | A$82.03 | — |
| 4000 mg powder | 1 | A$107 | — |
| 2000 mg suppository | 1 | A$45.80 | — |
| 4000 mg suppository | 1 | A$71.64 | — |
| 250 mg tablet | 1 | A$29.43 | A$0.29 |
Different strengths and forms (for example slow-release or dissolving tablets) are not interchangeable without your doctor's advice.
Other medicine prices in Australia
- Melphalan price1 productfrom A$48.32
- Memantine price7 productsfrom A$28.09
- Mepolizumab price1 productfrom A$1,556
- Mercaptopurine price4 productsfrom A$35.60
- Mesna price2 productsfrom A$51.74
- Metformin price48 productsfrom A$3.00
- Metformin and Saxagliptin price3 productsfrom A$36.54
- Metformin and Sitagliptin price29 productsfrom A$20.33
What people check next
Frequently asked questions
How much does mesalazine cost in Australia?
What kind of price is this?
How much will I pay for mesalazine at a pharmacy in Australia?
What is the cheapest mesalazine 1000 mg tablet in Australia?
Is mesalazine cheaper in other countries?
Sources
- Australian Government Department of Health, Disability and Ageing. Pharmaceutical Benefits Scheme (PBS) Schedule, 1 October 2026 (PBS API). www.pbs.gov.au/. Retrieved 25 October 2026.
- Australian Government Department of Health, Disability and Ageing (PBS). PBS patient co-payments from 1 January 2026: general A$25.00, concessional A$7.70 per script; Safety Net A$1,748.20 / A$277.20. pbs.gov.au/about/what-is-the-pbs/what-are-the-current-patient-fees-and. Retrieved 25 October 2026.
- European Central Bank. Euro foreign exchange reference rates (2026-10-23). www.ecb.europa.eu/stats/eurofxref/eurofxref-daily.xml. Retrieved 25 October 2026.
Important: These are published reference prices and estimates, not a quote, and not medical advice. Actual costs depend on the hospital, your health, the exact treatment and your insurance. Always confirm the price with the provider before treatment. Read our disclaimer · Report an error